MC LMS - 2026 ASKP3 Annual Conference: Building the Gold Standard: Advancing Excellence in Ketamine Therapy and Informing the Psychedelic Future

2026 ASKP3 Annual Conference: Building the Gold Standard: Advancing Excellence in Ketamine Therapy and Informing the Psychedelic Future

The 2026 Annual Conference theme, Building the Gold Standard: Advancing Excellence in Ketamine Therapy and Informing the Psychedelic Future, reflects the pivotal moment we are living in as clinicians, educators, and advocates in the ketamine field. Sessions were thoughtfully curated to support our shared commitment to advancing safe, effective, and ethical, evidence-informed care while actively shaping the future standards of practice for patients who depend on our leadership.

Course Details

For Distributors

Distributors may purchase multiple copies of packages to distribute to learners, and follow their progress. Bulk discounts are below.

Quantity	Price per voucher
1+	$0.00

Baseline PTSD and Depression Impact Real-World Ketamine Treatment Outcomes for PTSD	00:40:46
The Effects of Concomitant Psychotropic Medications on the Antidepressant Effects of IV Ketamine	00:29:44
Panel Discussion: Building Consensus—Shaping Standards for Ketamine Practice	00:28:26
IV Ketamine Therapy for Clinical Depression: The Impact of a Psychotherapist on the Care Team	00:40:59
Staying Compliant: Essential Legal Updates for Your Ketamine Practice	00:55:56
ASKP3 Annual Business Meeting	00:10:19
Synergism of IV Ketamine With Digital and Psychotherapeutic Interventions	00:56:29
At-Home Ketamine: Expanding Access or Expanding Risk?	00:45:12
Keynote Session: Glutamate – The Spark Behind the Storm and the Stillness	00:58:31
Ketamine Therapy for Existential Distress and End of Life	00:51:00
Psychologically Difficult IV Ketamine Infusions: Incidence Rates and In-Office Management	00:46:43
Ketamine in Dementia: Exquisitely Low Daily Dose Can Improve Mood and Cognition	00:39:18
Durability of Depressive and Suicidal Symptom Remission in Ketamine Maintenance Treatment	00:26:22
Advanced Integration: Ketamine With Neuromodulation	00:45:48
A Journey Through Music and Sound in Four Unique Clinical Approaches	00:49:19
Stellate Ganglion Block as Augmentation of Ketamine and Spravato Outcomes in 50 Patients	00:37:26
Multivariate Prediction of Short- and Long-Term Outcomes in Ketamine Treatment	00:28:58
Clinical Practice Patterns and Emergency Responses in Ketamine Therapy: Survey Findings and Implications for Medical Board Policy	00:44:41
IV Ketamine in Practice: Safety, Efficacy, and Long-Term Antidepressant Outcomes	00:56:53
Faculty Update and Therapist Advisory Panel Update	00:35:50
Outcomes of IV Ketamine Treatment in Adolescents With Depression: A Community Clinical Case Series	00:26:38